ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-65271

Client-side template injection (CSTI) in Azuriom CMS admin dashboard allows a low-privilege user to execute arbitrary template code in the context of an administrator's session.

Published Dec 8, 2025 · catalog updated Oct 18, 2026 · Client-side template injection (CSTI)

Open the advisory

Exploitation likelihood is not on this record for CVE-2025-65271. A missing EPSS score is not a low risk. Compare Client-side template injection (CSTI) with the linked advisory before you change production.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Client-side template injection (CSTI)).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
  • EPSS is missing. A missing score is not a low risk.
Severity
High8.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
Awaiting synchronization with FIRST
Remediation
Advisory link
Affected products
cpe azuriom/azuriom

Client-side template injection (CSTI) in Azuriom CMS admin dashboard allows a low-privilege user to execute arbitrary template code in the context of an administrator's session. This can occur via plugins or dashboard components that render untrusted user input, potentially enabling privilege escalation to an administrative account. Fixed in Azuriom 1.2.7.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe azuriom/azuriomversion unspecified

How to fix CVE-2025-65271

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

Exploitation likelihood is not on this record for CVE-2025-65271. A missing EPSS score is not a low risk. Compare Client-side template injection (CSTI) with the linked advisory before you change production.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-94: Code Injection. EPSS is not on this record yet. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 8, 2025 · NIST NVD

    Detected

    Client-side template injection (CSTI) in Azuriom CMS admin dashboard allows a low-privilege user to execute arbitrary template code in the context of an administrator's session. This can occur via plugins or dashboard components that render untrusted user input, potentially enabling privilege escalation to an administrative account. Fixed in Azuriom 1.2.7.

  2. Oct 18, 2026 · NIST NVD

    Updated

    Client-side template injection (CSTI) in Azuriom CMS admin dashboard allows a low-privilege user to execute arbitrary template code in the context of an administrator's session. This can occur via plugins or dashboard components that render untrusted user input, potentially enabling privilege escalation to an administrative account. Fixed in Azuriom 1.2.7.

Sources

  • CVE.orgVulnerability recordCVE-2025-65271

    Official CVE identifier

    cve.org
  • NIST NVDVulnerability recordCVE-2025-65271

    Client-side template injection (CSTI) in Azuriom CMS admin dashboard allows a low-privilege user to execute arbitrary template code in the context of an administrator's session. This can occur via plugins or dashboard components that render untrusted user input, potentially enabl

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.